SYN-TECH Chem. & Pharm Past Earnings Performance
Past criteria checks 5/6
SYN-TECH Chem. & Pharm has been growing earnings at an average annual rate of 13.9%, while the Pharmaceuticals industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 3.9% per year. SYN-TECH Chem. & Pharm's return on equity is 13.3%, and it has net margins of 26.9%.
Key information
13.9%
Earnings growth rate
2.2%
EPS growth rate
| Pharmaceuticals Industry Growth | 18.5% |
| Revenue growth rate | 3.9% |
| Return on equity | 13.3% |
| Net Margin | 26.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
SYN-TECH Chem. & Pharm (GTSM:1777) Could Easily Take On More Debt
Mar 19
Here's What You Should Know About SYN-TECH Chem. & Pharm. Co., Ltd.'s (GTSM:1777) 4.6% Dividend Yield
Feb 26Declining Stock and Decent Financials: Is The Market Wrong About SYN-TECH Chem. & Pharm. Co., Ltd. (GTSM:1777)?
Feb 05
SYN-TECH Chem. & Pharm's (GTSM:1777) Shareholders Are Down 11% On Their Shares
Jan 10SYN-TECH Chem. & Pharm (GTSM:1777) Seems To Use Debt Rather Sparingly
Dec 19Here's What You Should Know About SYN-TECH Chem. & Pharm. Co., Ltd.'s (GTSM:1777) 4.6% Dividend Yield
Nov 28Revenue & Expenses Breakdown
How SYN-TECH Chem. & Pharm makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,215 | 327 | 92 | 41 |
| 30 Jun 24 | 1,215 | 304 | 91 | 42 |
| 31 Mar 24 | 1,117 | 273 | 90 | 38 |
| 31 Dec 23 | 1,115 | 251 | 90 | 38 |
| 30 Sep 23 | 1,091 | 249 | 93 | 39 |
| 30 Jun 23 | 1,042 | 270 | 91 | 40 |
| 31 Mar 23 | 1,058 | 306 | 90 | 40 |
| 31 Dec 22 | 986 | 295 | 90 | 40 |
| 30 Sep 22 | 883 | 318 | 82 | 39 |
| 30 Jun 22 | 781 | 230 | 78 | 36 |
| 31 Mar 22 | 854 | 180 | 85 | 39 |
| 31 Dec 21 | 893 | 177 | 86 | 36 |
| 30 Sep 21 | 972 | 166 | 86 | 33 |
| 30 Jun 21 | 1,012 | 175 | 88 | 32 |
| 31 Mar 21 | 984 | 192 | 80 | 27 |
| 31 Dec 20 | 984 | 187 | 82 | 27 |
| 30 Sep 20 | 1,028 | 183 | 84 | 26 |
| 30 Jun 20 | 1,081 | 205 | 84 | 26 |
| 31 Mar 20 | 987 | 166 | 83 | 27 |
| 31 Dec 19 | 946 | 159 | 78 | 27 |
| 30 Sep 19 | 882 | 167 | 76 | 28 |
| 30 Jun 19 | 795 | 139 | 75 | 28 |
| 31 Mar 19 | 788 | 168 | 74 | 28 |
| 31 Dec 18 | 785 | 154 | 73 | 29 |
| 30 Sep 18 | 729 | 130 | 67 | 27 |
| 30 Jun 18 | 699 | 111 | 66 | 28 |
| 31 Mar 18 | 701 | 83 | 66 | 28 |
| 31 Dec 17 | 695 | 60 | 68 | 30 |
| 30 Sep 17 | 737 | 85 | 73 | 35 |
| 30 Jun 17 | 747 | 100 | 75 | 35 |
| 31 Mar 17 | 742 | 112 | 78 | 35 |
| 31 Dec 16 | 767 | 158 | 76 | 34 |
| 30 Sep 16 | 758 | 161 | 73 | 31 |
| 30 Jun 16 | 768 | 189 | 68 | 30 |
| 31 Mar 16 | 727 | 166 | 62 | 28 |
| 31 Dec 15 | 684 | 156 | 60 | 27 |
| 30 Sep 15 | 651 | 154 | 58 | 26 |
| 30 Jun 15 | 632 | 138 | 59 | 25 |
| 31 Mar 15 | 624 | 138 | 58 | 25 |
| 31 Dec 14 | 609 | 128 | 58 | 25 |
| 30 Sep 14 | 579 | 108 | 55 | 24 |
| 30 Jun 14 | 536 | 84 | 50 | 23 |
| 31 Mar 14 | 528 | 80 | 50 | 23 |
| 31 Dec 13 | 502 | 78 | 46 | 23 |
Quality Earnings: 1777 has high quality earnings.
Growing Profit Margin: 1777's current net profit margins (26.9%) are higher than last year (22.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1777's earnings have grown by 13.9% per year over the past 5 years.
Accelerating Growth: 1777's earnings growth over the past year (31.6%) exceeds its 5-year average (13.9% per year).
Earnings vs Industry: 1777 earnings growth over the past year (31.6%) exceeded the Pharmaceuticals industry 11.9%.
Return on Equity
High ROE: 1777's Return on Equity (13.3%) is considered low.